Rabeprazole Sodium DR
This contract has been archived. It is preserved as a historical record.
Similar active opportunities:
This opportunity has closed
Similar active opportunities you might be interested in:
View all similar opportunitiesKey Takeaways
- No response deadline specified - contact the agency for details
- Full and open competition - all businesses eligible to bid
- Work to be performed in PHILADELPHIA, PA
- Industry: Pharmaceutical Preparation Manufacturing
Contract Details
- Notice ID
- SPE2D2-25-R-0006
- Opportunity Type
- Presolicitation
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEFENSE LOGISTICS AGENCY
- Office
- DLA TROOP SUPPORT
- Posted Date
- Tuesday, February 11, 2025
- Response Deadline
- Not specified
- PSC Code
- 6505
- Set-Aside
- Full & Open Competition
- Place of Performance
- PHILADELPHIA, PA, 19111
- Status
- Active
Description
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. Procurement details follow. Rabeprazole Sodium DR 20MG in 30, 90 and 500 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual estimated usage estima
Why This Opportunity Matters
The Department of DEFENSE is actively seeking qualified contractors for pharmaceutical preparation manufacturing in PHILADELPHIA, PA.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
